prulifloxacin has been researched along with Prostatitis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (83.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Busetto, GM; De Berardinis, E; De Cobelli, O; Del Giudice, F; Ferro, M; Gentile, V; Giovannone, R; Matei, DV; Tricarico, S | 1 |
Barattè, S; Dionisio, P; Gallo, F; Giberti, C; Picollo, R; Rosignoli, MT; Ruggieri, A | 1 |
Addonisio, P; Bartoletti, R; Bechi, A; Cai, T; Mazzoli, S; Mondaini, N; Pagliai, RC | 1 |
Autorino, R; Giannarini, G | 1 |
Barbone, F; De Maria, M; Giannarini, G; Manassero, F; Mogorovich, A; Morelli, G; Selli, C; Valent, F | 1 |
4 trial(s) available for prulifloxacin and Prostatitis
Article | Year |
---|---|
Chronic bacterial prostatitis: efficacy of short-lasting antibiotic therapy with prulifloxacin (Unidrox®) in association with saw palmetto extract, lactobacillus sporogens and arbutin (Lactorepens®).
Topics: Adult; Anti-Bacterial Agents; Arbutin; Bacterial Infections; Chronic Disease; Combined Modality Therapy; Dietary Supplements; Dioxolanes; Drug Administration Schedule; Fluoroquinolones; Humans; Lactobacillus; Male; Middle Aged; Piperazines; Plant Extracts; Prostatitis; Recurrence; Serenoa; Young Adult | 2014 |
Penetration of orally administered prulifloxacin into human prostate tissue.
Topics: Administration, Oral; Anti-Bacterial Agents; Biological Availability; Dioxolanes; Fluoroquinolones; Humans; Male; Middle Aged; Piperazines; Prostate; Prostatic Hyperplasia; Prostatitis; Transurethral Resection of Prostate | 2009 |
Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study.
Topics: Adult; Anti-Bacterial Agents; Curcumin; Dioxolanes; Flavonoids; Fluoroquinolones; Follow-Up Studies; Humans; Male; Piperazines; Prospective Studies; Prostatitis; Quality of Life; Secondary Prevention; Serenoa; Surveys and Questionnaires; Treatment Outcome; Urtica dioica; Young Adult | 2009 |
Prulifloxacin versus levofloxacin in the treatment of chronic bacterial prostatitis: a prospective, randomized, double-blind trial.
Topics: Adult; Anti-Bacterial Agents; Chronic Disease; Dioxolanes; Double-Blind Method; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Piperazines; Prospective Studies; Prostatitis; Quinolones | 2007 |
2 other study(ies) available for prulifloxacin and Prostatitis
Article | Year |
---|---|
Re: Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study.
Topics: Anti-Bacterial Agents; Curcumin; Dioxolanes; Drug Synergism; Fluoroquinolones; Humans; Male; Phytotherapy; Piperazines; Plant Extracts; Prostatitis; Quercetin; Serenoa; Urtica dioica | 2009 |
Prulifloxacin. NAD-441A, NM 441, Quisnon.
Topics: Animals; Anti-Infective Agents; Dioxolanes; Drug Interactions; Enteritis; Fluoroquinolones; Humans; Male; Mice; Piperazines; Prostatitis; Quinolones; Respiratory Tract Infections; Surgical Wound Infection | 2002 |